Skip to product information

Gynaecological & Breast Cancers Screening

Gynaecological & Breast Cancers Screening

Regular price $5,888.00
Regular price Sale price $5,888.00
Save Sold out
10 People are looking at this
View full details
Selected Variant Image
Gynaecological & Breast Cancers Screening
Regular price $5,888.00
Regular price Sale price $5,888.00
Selected Variant Image
Gynaecological & Breast Cancers Screening
Regular price $5,888.00
Regular price Sale price $5,888.00
  • Description

  • Why Us?

The essence of screening is to detect the major female concerning disease among the healthy populations without symptoms of the disease with the primary purpose of reducing the morbidity and mortality with the disease.

Pap smear (Age 21 or above) - can help to detect :
 - Cervical Cancer
- Uterine / Endometrial Cancers

Pelvic Examination - can help to detect :
- Cervical Cancer
- Ovarian Cancer

Purchase Remarks: Doctors to conduct health consultation, physical examination and result report interpretation.

Doctor Consultation
 - Detailed Medical History
 - Explanation of a report by Doctor.
 * if < 40 years old, may recommend for Ultrasound Breast after Doctor Consultation
Imaging Examination
 - Ultrasound Pelvis
 - Mammogram (2D) - Both Side
Lab Test :
 - Cancer Marker : CA 125 (Ovary)
 - Cancer Marker: CA 15.3 (Breast)
 - Pap Smear

Clearbridge Health Limited is an integrated healthcare group with a focus on the delivery of precision medicine with businesses comprising of laboratory testing services, medical centres/clinics and strategic equity participation in complementary precision medical technology companies. We are present in more than 10 countries around the world and have plans to further expand our presence in Pan Asia. Working closely with healthcare professionals and globally-accredited laboratories, Clearbridge Health offers patient care through precision diagnostics, empowers clinicians and healthcare professionals to make reliable and accurate diagnoses, providing fresh insights into disease management, customising prevention and treatment programmes that are personalised and timely. Listed on the Catalist Board of the SGX-ST, Clearbridge Health Limited Group of Companies continues to provide effective ways to detect cancer, critical illness, and other lifestyle diseases in the world today.

VISION
Redefining healthcare in Asia with precision.
Empowering patient care with clarity.

MISSION
Setting a new standard for personalized care through the integration of healthcare services, medical technology and data science.

CORE VALUES
Kindness You always come first
Confidence We believe that better outcomes start with precise insights
Dependability Our people – they are our edge
Respect Professionalism in every circumstance
Trust Delivering healthcare services with utmost integrity